omalizumab urticaria
Selected indexed studies
- Chronic Spontaneous Urticaria: A Review. (JAMA, 2024) [PMID:39325444]
- Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence. (Clin Rev Allergy Immunol, 2020) [PMID:32418171]
- Urticaria. (Nat Rev Dis Primers, 2022) [PMID:36109590]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence. (2020) pubmed
- Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis. (2024) pubmed
- Chronic Spontaneous Urticaria: A Review. (2024) pubmed
- Urticaria. (2022) pubmed
- Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. (2017) pubmed
- Urticaria and Angioedema: an Update on Classification and Pathogenesis. (2018) pubmed
- Omalizumab in chronic urticaria. (2012) pubmed
- Omalizumab for cholinergic urticaria: 6 months prospective study and systematic review of the literature. (2020) pubmed
- Omalizumab for chronic urticaria in children younger than 12 years. (2019) pubmed
- Recent updates in urticaria. (2023) pubmed